S
Seong Joon Kim
Researcher at Seoul National University Hospital
Publications - 161
Citations - 1926
Seong Joon Kim is an academic researcher from Seoul National University Hospital. The author has contributed to research in topics: Visual acuity & Exotropia. The author has an hindex of 18, co-authored 158 publications receiving 1482 citations. Previous affiliations of Seong Joon Kim include New Generation University College & Seoul National University.
Papers
More filters
Journal ArticleDOI
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.
Sung Min Kim,Mark Woodhall,Ji Sun Kim,Seong Joon Kim,Kyung Seok Park,Angela Vincent,Kwang Woo Lee,Patrick Waters +7 more
TL;DR: MOG-Abs may be a disease-specific biomarker in adult patients with IDD who have a disease distinct from NMO or MS, and the radiologic as well as clinical manifestations of MOG-Ab patients can be useful in their differential diagnosis.
Journal ArticleDOI
Incidence and Clinical Features of Ethambutol-Induced Optic Neuropathy in Korea
TL;DR: Renal dysfunction and daily dose of eth Ambutol, but not duration of ethambutol treatment, seem to be related to development of EON.
Journal ArticleDOI
Correlation of Visual Acuity with Foveal Hypoplasia Grading by Optical Coherence Tomography in Albinism
Je Hyun Seo,Young Suk Yu,Young Suk Yu,Jeong Hun Kim,Jeong Hun Kim,Ho Kyung Choung,Ho Kyung Choung,Jang Won Heo,Jang Won Heo,Seong Joon Kim,Seong Joon Kim +10 more
TL;DR: The prognostic value of foveal hypoplasia as assessed by OCT in young patients with albinism is superior to grades based on iris transillumination or macular transparency.
Journal ArticleDOI
Differential diagnosis of neuromyelitis optica spectrum disorders.
TL;DR: Despite some similarity in their phenotypes, these NMOSD andNMOSD-mimics are distinct from each other in their pathogenesis, prognosis, and most importantly treatment.
Journal ArticleDOI
Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
Haeng Jin Lee,Boram Kim,Patrick Waters,Mark Woodhall,Sarosh R. Irani,Sohyun Ahn,Seong Joon Kim,Sung Min Kim +7 more
TL;DR: Among iON patients with MOG-IgG, the absence of steroid-dependent attacks in the early stages of the disease may predict a long-term non-relapsing disease course and a more favorable outcome, according to the current diagnostic criteria.